Compare Powell Industries (POWL) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Powell Industries vs Repligen Corporation Common Stock — how do they compare? Powell Industries trades at $164.99 (market cap $6.18B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Powell Industries pays a 0.21% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Powell Industries for 6 Days and Repligen Corporation Common Stock for 0 Days on average.
| POWL | RGEN | |
|---|---|---|
Market Cap | $6.18B | $11.31B |
Volume | 1,083,698 | 1,216,919 |
Sector | Industrials | Health |
52-Week High | $322.05 | $194.57 |
52-Week Low | $94.02 | $102.87 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $5.55B | $11.20B |
Dividend Yield | 0.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Powell Industries (POWL) trades at $182.79, down 1.4% with bearish technical signals. The company shows strong profitability with 16.49% net margin and 28.25% ROE, though recent quarters missed earnings estimates. Analyst consensus is mixed with 30% buy ratings but a $284 price target suggesting 55% upside. The stock faces near-term pressure from technical weakness despite solid fundamentals and a $2.4 billion backlog supporting future growth.
The investment case balances strong operational performance against technical headwinds. Upside potential exists from backlog conversion and capacity expansion, but risks include execution challenges and market volatility. With valuation metrics elevated (P/E 34.99), successful earnings delivery in upcoming quarters remains critical for sustaining investor confidence and achieving analyst targets.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Powell Industries
Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
